Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
P/FCF Ratio Over TimeExpanding
Percentile Rank83
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-1.32
↑ 78% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-6.08
Historical baseline
PeriodValueYoY Change
2025-1.32+70.0%
2024-4.41+20.0%
2023-5.51-49.2%
2022-3.69+70.2%
2021-12.39+18.8%
2020-15.26-
20190.00-